Literature DB >> 23912997

Western blots.

Lita A Freeman1.   

Abstract

Western analysis of apolipoproteins, lipoproteins, and proteins involved in lipoprotein metabolism can be challenging due to their size, hydrophobic nature, and, in some cases, low abundance. Here we describe a Western blotting method that has been used successfully for many proteins involved in lipoprotein metabolism, as well as intact LDL or HDL particles. Proteins or lipoprotein particles separated by gel electrophoresis are transferred to a PVDF membrane in a Hoefer TE22 transfer tank with Tris-Glycine-SDS-Methanol transfer buffer. The membrane is blocked with 3 % BSA/5 % milk to prevent nonspecific binding of antibody to the membrane and is then incubated with primary antibody that binds specifically to the protein of interest. After washing away unbound primary antibody, the membrane is then incubated with an HRP-labeled secondary antibody that binds primary antibody. After washing away unbound secondary antibody, the membrane is then incubated with a substrate for HRP, generating a chemiluminescent signal at the location of the protein of interest. The protein is visualized by exposing the membrane to an autoradiography film or an imaging device. Information on the use of several human antibodies, including apoA-I, A-II, apoB, apoC-II, apoC-III, apoD, apoL1, apoM, PON1, SAA, ABCA1, nitrotyrosine, and LCAT, is provided. This method can be used for Western blotting of virtually any protein as well as native lipoprotein particles.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912997     DOI: 10.1007/978-1-60327-369-5_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice.

Authors:  Sophie Stukas; Lita Freeman; Michael Lee; Anna Wilkinson; Alice Ossoli; Boris Vaisman; Stephen Demosky; Jeniffer Chan; Veronica Hirsch-Reinshagen; Alan T Remaley; Cheryl L Wellington
Journal:  J Lipid Res       Date:  2014-06-20       Impact factor: 5.922

2.  Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter.

Authors:  D O Sviridov; S K Drake; L A Freeman; A T Remaley
Journal:  Biochem Biophys Res Commun       Date:  2016-02-12       Impact factor: 3.575

3.  The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties.

Authors:  Anna Schwendeman; Denis O Sviridov; Wenmin Yuan; Yanhong Guo; Emily E Morin; Yue Yuan; John Stonik; Lita Freeman; Alice Ossoli; Seth Thacker; Salena Killion; Milton Pryor; Y Eugene Chen; Scott Turner; Alan T Remaley
Journal:  J Lipid Res       Date:  2015-06-27       Impact factor: 5.922

4.  Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.

Authors:  Toshihiro Sakurai; Akiko Sakurai; Boris L Vaisman; Marcelo J Amar; Chengyu Liu; Scott M Gordon; Steven K Drake; Milton Pryor; Maureen L Sampson; Ling Yang; Lita A Freeman; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

5.  Interleukin 10 promotes macrophage uptake of HDL and LDL by stimulating fluid-phase endocytosis.

Authors:  Diego Lucero; Promotto Islam; Lita A Freeman; Xueting Jin; Milton Pryor; Jingrong Tang; Howard S Kruth; Alan T Remaley
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-10-30       Impact factor: 4.698

6.  TRIBE Uncovers the Role of Dis3 in Shaping the Dynamic Transcriptome in Malaria Parasites.

Authors:  Meng Liu; Binbin Lu; Yanting Fan; Xiaohui He; Shijun Shen; Cizhong Jiang; Qingfeng Zhang
Journal:  Front Cell Dev Biol       Date:  2019-11-01

7.  Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen.

Authors:  Diego Lucero; Ozan Dikilitas; Michael M Mendelson; Zahra Aligabi; Promotto Islam; Edward B Neufeld; Aruna T Bansal; Lita A Freeman; Boris Vaisman; Jingrong Tang; Christian A Combs; Yuesheng Li; Szilard Voros; Iftikhar J Kullo; Alan T Remaley
Journal:  J Lipid Res       Date:  2021-12-10       Impact factor: 5.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.